ROTUOC
TNYA icon

Regents of the University of California’s Tenaya Therapeutics TNYA Stock Holding History

Regents of the University of California’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,633
Closed -$97.6K – 30
2023
Q2 		$97.6K Sell
16,633
-944,324
-98% -$5.49M 0.01% 28
2023
Q1 		$2.74M Sell
960,957
-665,793
-41% -$1.87M 0.51% 7
2022
Q4 		$3.27M Hold
1,626,750
– – 0.62% 6
2022
Q3 		$4.72M Buy
+1,626,750
New +$7.59M 0.96% 6

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Regents of the University of California's TNYA Position: Q3 2023 in Review

Regents of the University of California sold out of Tenaya Therapeutics (TNYA) in Q3 2023, closing a stake of 16,633 shares — an estimated $97.6K sold.

Regents of the University of California first reported a position in TNYA in Q3 2022 and held it in 4 quarters. The position peaked at $4.72M in Q3 2022. 76 funds tracked by Wall St. Rank hold TNYA as of Q3 2023.

  • Regents of the University of California reported no remaining Tenaya Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Regents of the University of California sold 16,633 Tenaya Therapeutics shares in Q3 2023, an estimated $97.6K.
  • Regents of the University of California first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 4 quarters.
  • Regents of the University of California's Tenaya Therapeutics position peaked at $4.72M in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2023.

Based on Regents of the University of California's 13F filing for Q3 2023, filed 12 Oct 2023.